Faeth Therapeutics, Inc. (SNSE)

SEC filing

Faeth Therapeutics, Inc.

SNSE · CIK 1829802

4 · May 15, 2026 · ENGLANDER ISRAEL A bought 30.59K shares at $26.75/share ($818.3K); sold 3,250 shares at $27.50/share ($89,390)

ENGLANDER ISRAEL A bought 30.59K shares at $26.75/share ($818.3K); sold 3,250 shares at $27.50/share ($89,390)

OWNERSHIP DOCUMENT

xslF345X06/tm2614687-2_4seq1.xmlSEC.gov

Graphics and non-inline formats (not embedded below).